The Avalus pericardial surgical valve is intended for patients with aortic valve disease.
Medtronic will keep its respiratory and monitoring solutions business, while Cardinal will buy the patient care, DVT, and nutritional insufficiency businesses.
The adjustable devices have been the subject of an increased product complaint rate.
The technology helps doctors find the origin of an irregular heart rhythm.
The device expands treatment to an additional patient population.
The IN.PACT Admiral device will provide a new treatment option for PAD patients.
The cognitive app that aims to make daily diabetes management easier and more informative is in the final development stage.
Medtronic wins FDA approval for the world’s smallest pacemaker.
Cultivating fresh thinking and continual adaptation is key.
Announced at CES 2016, the cognitive app will leverage predictive analytics to help patients better manage their condition.